| dc.contributor.author | González Velásquez, Tania | spa |
| dc.contributor.author | Barboza Ubarnes, Miriam | spa |
| dc.date.accessioned | 2020-12-21 00:00:00 | |
| dc.date.available | 2020-12-21 00:00:00 | |
| dc.date.issued | 2020-12-21 | |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | 10.32997/rcb-2011-3069 | |
| dc.identifier.eissn | 2389-7252 | |
| dc.identifier.issn | 2215-7840 | |
| dc.identifier.uri | https://hdl.handle.net/11227/13338 | |
| dc.identifier.url | https://doi.org/10.32997/rcb-2011-3069 | |
| dc.language.iso | spa | spa |
| dc.publisher | Universidad de Cartagena | spa |
| dc.relation.bitstream | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3069/2600 | |
| dc.relation.citationedition | Núm. 2 , Año 2011 | spa |
| dc.relation.citationendpage | 296 | |
| dc.relation.citationissue | 2 | spa |
| dc.relation.citationstartpage | 289 | |
| dc.relation.citationvolume | 2 | spa |
| dc.relation.ispartofjournal | Revista Ciencias Biomédicas | spa |
| dc.relation.references | Garcia H, Brutto O. For the cisticercosis working Groupin Perú. Neurocysticercosis:Updated concepts about and old disease. Lancet Neurol 2005;4: 653-61. | spa |
| dc.relation.references | Agudelo P, Botero D, Palacio G. Evaluación del método de ELISA de punto para el diagnóstico de la cisticercosis humana y para estimar valores de prevalencia en una región endémica en Colombia. Biomédica. 2005; 25: 40-43. | spa |
| dc.relation.references | Flórez AC, Rojas R, Montero YA. Estudio retrospectivo de seroprevalencia de Neurocisticercosis en pacientes colombianos que acudieron al Instituto Nacional de Salud, durante un período de 10 años (1995 – 2005). Programa de Vigilancia por el Laboratorio. Infectio 2006 10(2): 98 | spa |
| dc.relation.references | Bonelo A, Carvajal H. Cisticercosis en pacientes con cuadro neurológico en Cali, Facultad de Salud, Universidad del Valle, Cali. Biomédica. Santa Fe de Bogotá Suplemento jul. 1993; 96 | spa |
| dc.relation.references | Vasquez L, Ortiz J, Velasco A, González F. Neurocisticercosis: casos clínicos presentes en el hospital universitario San José Popayán, 1994 – 1999. Infect. 2000, 4, (1): 51-52. | spa |
| dc.relation.references | Sanzón A. Prevalencia de anticuerpos contra cisticercos. Colombia médica Cali, 1991; 22: 98- 100. | spa |
| dc.relation.references | Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-1734. | spa |
| dc.relation.references | Giménez-Roldán S, Díaz F, Esquivel A. Neurocisticercosis e inmigración. Neurología 2003; 18: 385-388. | spa |
| dc.relation.references | Pal DK, Carpio A, Sander JWAS. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000; 68; 137-143. | spa |
| dc.relation.references | Kalra V, Sethi A. childhood neurocysticercosis – epidemiology diagnosis and course. Acta Peaditr Jpn, 1992, 34 :365-70 | spa |
| dc.relation.references | Aguilar F. Perfil de la neurocisticercosis en niños mexicanos. Cir Ciruj 1998; 66:86-89. | spa |
| dc.relation.references | Gaffo AL, Guillen-Pinto D, Campos-Olazábal P, Burneo JG. Cisticercosis, la causa principal de crisis parciales en niños en Peru. Rev Neurol 2004; 39: 924-926. | spa |
| dc.relation.references | Hauser WA, Pellock JM Dodson WE. Epidemiology of epilepsy in children. Pediatric epilepsy: diagnosis and therapy. 2001;12: 81-96. | spa |
| dc.relation.references | Carod-Artal F. Causas tropicales de epilepsia.Rev Neurol 2009;49:475-82 | spa |
| dc.relation.references | Botero D, Restrepo M. Parasitosis humana. Editorial Colombia Corporación Para La Investigaciones Biológicas; 4rt edición. Medellín, Colombia.2003. | spa |
| dc.relation.references | Sighi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Chil Neurol 2000; 15: 207-213. | spa |
| dc.relation.references | Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimora S. Neurocysticercosis in children: clinical study and follow-up of 112 patients. Rev Neurol 2006; 42 Supl 3: 97-101. | spa |
| dc.relation.references | Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM. Clinical aspects of neurocisticercosis in children. Pediatr Neurol 2000; 22: 287-289. | spa |
| dc.relation.references | Ruiz-García M. Neurocysticercosis in children. Clinical experience in 122 patients. Child Nerv Syst 1997; 13: 608-612. | spa |
| dc.relation.references | Cuéllar R, Molinero M, Ramírez F, Vallejo V. Manifestaciones clínicas de la neurocisticercosis cerebral activa en pediatría. Rev Neurol 1999; 29: 334-337. | spa |
| dc.relation.references | Osborne AG. Diagnostic Neuroradiology. Editorial Mosby; 1 edición. St. Louis, Estados Unidos America (MO). 1994. | spa |
| dc.relation.references | Noujaim SE, Rossi MD, Rao SK, Cacciarelli AA, Mendonca RA, Wang AM et al. CT and MR Imaging of neurocysticercosis. AJR Am J Roentgenol. 1999;173:1485-1490. | spa |
| dc.relation.references | Castillo M. Imaging of neurocysticercosis. Semin Roentgenol.2004;39:465-473. | spa |
| dc.relation.references | Sheth TN, Pilon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol. 1998;19:79-82. | spa |
| dc.relation.references | Nash TE, Pretell EJ, Lezcano AG, Busto JA, Gilman RH, González AE, et al; Cysticercosis Working Group in Peru. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008; 7: 1099-1105. | spa |
| dc.relation.references | Kalra V, Sethi A. Childhood neurocysticercosis epidemiology, diagnosis and course. Acta Paediatr Jpn 1992;34:365-370 | spa |
| dc.relation.references | Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57: 177–183. | spa |
| dc.relation.references | Sotello J, Del Brutto O. Therapy of Neurocysticercosis in Childs - Nerv Sist 1987; 3: 208-211. | spa |
| dc.relation.references | Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial.J.Pediatr.2003;143:111-114. | spa |
| dc.relation.references | Carpio A, Kelvin EA, Bagiella E, Leslie D. The Ecuadonan Neurocysticercosis Group. Effects of albendazole treatment on neurocysticercosis: A randomized controlled trial.J.Neurol Neurosurg Psyshiatry.2008;79:1050-1055. | spa |
| dc.relation.references | Thakur C, Anand K. Childhood Neurocysticercosis in South India. Ind. J. Ped. 1991; 58: 805-9. | spa |
| dc.relation.references | Kalra V. Sethia - Chilhood Neurocysticercosis Epidemiolog, Diagnosis and course. act. Pedia JPS 1992; 34: 365-70. | spa |
| dc.relation.references | Sotello J, del Brutto O. Therapy of Neurocysticercosis in Childs - Nerv Sist 1987; 3: 208-11 | spa |
| dc.relation.references | Cutter AC. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2003; 60: 1873-4. | spa |
| dc.relation.references | Fernández R, Ortiz R, Pío A, Peña A. Alternativas quirúrgicas en el tratamiento de la neurocisticercosis. Rev. neuropsiquiatr 2005; 68:153-171. | spa |
| dc.relation.references | Colli B, Martelli N, Machado H, Salvarani C, Sassoli V, Forjaz S. Cysticercosis of the central nervous system I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School. Arq Neuropsiquiatr 1994;52(2):166-186. | spa |
| dc.relation.references | Sciutto E, Fragoso G. Vaccine:Cysticercosis. Vaccine 2005; 23: 4062-4064. | spa |
| dc.relation.references | Huerta M., A. S. de Aluja G, Fragoso A, Toledo N, Villalobos M, Hernández G. “Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico”, Vaccine 2005; 20:262-266. | spa |
| dc.relation.references | Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimora S.Neurocysticercosis in children: clinical study and follow-up of 112 patients. Rev Neurol 2006; 42 (Supl 3): 97-101. | spa |
| dc.relation.references | Sighi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Chil Neurol 2000; 15: 207-13. | spa |
| dc.relation.references | Fleury A, Gómez I, Álvarez D,Meza M, Huerta A, Chavarría R. “High prevalence of calcified silent neurocysticercosis in a rural village of Mexico”, Neuroepidemiology 2003; 22: 139-145. | spa |
| dc.rights | Revista Ciencias Biomédicas - 2020 | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | spa |
| dc.source | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3069 | spa |
| dc.subject | Cisticercosis. Neurocisticercosis. Taenia solium. | spa |
| dc.title | Neurocisticercosis en niños | spa |
| dc.title.translated | Neurocisticercosis en niños | eng |
| dc.type | Artículo de revista | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
| dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/article | spa |
| dc.type.local | Journal article | eng |
| dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
| dspace.entity.type | Publication |
Sede: Claustro de San Agustín, Centro Histórico, Calle de la Universidad Cra. 6 #36-100
Colombia, Bolívar, Cartagena
Ver más...
